NOVA T3
NOVA‑T3 Tablet by NovaTech Sciences contains Liothyronine Sodium (CAS 55‑06‑1). Trusted manufacturer, supplier, and exporter of pharmaceutical‑grade thyroid support for hormone balance and metabolic health.
CAS Number: 55-06-1
NOVA T3 (Liothyronine Sodium T3 50 mcg) is indicated for the treatment of hypothyroidism and other thyroid-related hormonal imbalances. It supports healthy metabolism, energy regulation, and thyroid function. Some athletes and bodybuilders use T3 under supervision for metabolism enhancement and fat-loss during cutting cycles.
NOVA-T3 by Nova Techsciences is presented as an oral tablet containing Liothyronine Sodium 50 mcg. Liothyronine Sodium is a synthetic form of triiodothyronine, commonly known as T3, and is identified by CAS Number 55-06-1. T3 is an active thyroid hormone involved in regulating metabolism, growth, energy use and several essential body functions.
Liothyronine is a prescription thyroid medicine. In authorised clinical settings, it may be considered for severe thyroid-hormone deficiency, selected hypothyroid conditions and certain specialist-managed situations. NHS England advises that most hypothyroidism is treated with levothyroxine alone, while liothyronine may be appropriate for a limited group of patients following specialist assessment.
NOVA-T3 Product Overview
- Product name: NOVA-T3
- Active compound: Liothyronine Sodium
- Strength: 50 mcg per tablet
- Dosage form: Oral tablet
- CAS Number: 55-06-1
- Brand: Nova Techsciences
The NOVA-T3 label should clearly identify the complete composition, excipients, tablet quantity, batch number, manufacturing date, expiry date and approved storage conditions. Information displayed on the product page should remain consistent with the packaging, Certificate of Analysis and applicable regulatory documents.
Quality Control and Traceability
Thyroid-hormone tablets require precise manufacturing controls because small variations in strength may affect treatment outcomes. Relevant quality checks may include raw-material identification, active-ingredient assay, tablet content uniformity, dissolution testing, impurity analysis, stability assessment and packaging-integrity verification.
Each NOVA-T3 batch should have a unique identification number linked to its manufacturing and laboratory-release records. Claims relating to purity, quality or manufacturing standards should only be published when supported by current documentation.
For the United Kingdom, Netherlands and other European markets, the page should clearly disclose the medicine’s marketing-authorisation status, prescription category, responsible manufacturer and adverse-event reporting process.
Important Safety Information
Excess thyroid-hormone exposure may produce symptoms such as palpitations, rapid heartbeat, sweating, tremor, anxiety, sleep disturbance, diarrhoea, muscle weakness or unexplained weight changes. People with untreated adrenal insufficiency, thyrotoxicosis or certain cardiovascular conditions require particular caution and professional assessment.
NOVA-T3 should not be presented as a general weight-loss, fat-burning, bodybuilding or metabolism-enhancement product. Patients should not begin, change or discontinue thyroid treatment without medical guidance and appropriate thyroid-function monitoring.
Related Nova Techsciences Products
NOVA-T4
NOVA-T4 is presented as a Levothyroxine Sodium 50 mcg tablet. Levothyroxine is synthetic T4 and is commonly used as thyroid-hormone replacement. Product records should clearly distinguish levothyroxine CAS 51-48-9 from levothyroxine sodium CAS 55-03-8.
NOVABOL
NOVABOL contains Oxandrolone 10 mg, identified by CAS Number 53-39-4. Oxandrolone is an anabolic-androgenic steroid with separate liver, cardiovascular, hormonal and reproductive risks. It requires its own regulatory documentation and must not be treated as a thyroid medicine.
NOVAMETH
NOVAMETH contains Methandienone 10 mg, identified by CAS Number 72-63-9. It is an oral anabolic-androgenic compound with a different chemical and safety profile from Liothyronine Sodium. Its information should prioritise legal status, contraindications, liver-related warnings and responsible medical oversight.
NOVAMOREN
NOVAMOREN is presented as an Ibutamoren Mesylate product associated with CAS Number 159752-10-0. Ibutamoren is a growth-hormone secretagogue under clinical investigation; an EMA orphan designation does not constitute marketing authorisation. Its regulatory status must therefore be stated accurately.
NOVAZOLE
NOVAZOLE contains Anastrozole 1 mg, identified by CAS Number 120511-73-1. Anastrozole is an aromatase inhibitor used in authorised settings for specific hormone-dependent breast cancers. It is distinct from thyroid medicines and requires separate contraindications, bone-health precautions and prescribing information.
NOVA-T3 should ultimately be presented through accurate chemical identification, precise strength information, transparent batch documentation, balanced safety guidance and clearly stated regulatory status.
Important Information & FAQs
Precautions & Contraindications
Precautions
- Use NOVA T3 only under medical supervision.
- Start with the lowest effective dose to prevent overstimulation.
- Monitor heart rate, blood pressure, and thyroid function.
- Avoid unsupervised use during fat-loss or steroid cycles.
- Stay hydrated and maintain electrolyte balance.
- Keep out of reach of children and store in a cool, dry place.
Contraindications
- Do not use NOVA T3 if allergic to Liothyronine Sodium or similar thyroid medicines.
- Avoid if untreated hyperthyroidism, adrenal disorders, or severe cardiac conditions exist.
- Do not combine with stimulants or strong fat-burners.
- Avoid alcohol or recreational substances that interfere with metabolism.
- Seek immediate medical attention for chest pain, irregular heartbeat, extreme anxiety, or unusual symptoms.
Related Products
AROMANOVA
High-potency Exemestane tablets for advanced estrogen control and PCT support.
CABERNOVA
Premium Cabergoline tablets for prolactin control, hormone support, and enhanced recovery.
CLOMINOVA
Clomiphene Citrate 50 mg tablets for post-cycle therapy, testosterone recovery, and hormonal balance.
ENCLOMINOVA
Premium Enclomiphene Citrate tablets for testosterone boosting, PCT recovery, and hormonal balance.